Showing 35,532 results

Injectable & long-acting PrEP

Injected PrEP: cabotegravir maintains its advantage over four years

News
17 February 2022

CROI 2022: Epatite C in calo tra le persone HIV+ grazie all’aumentato accesso alle terapie, Notizie da CROI 2022

February 2022

КРОИ 2022: Заболеваемость вирусным гепатитом С снижается среди ВИЧ-инфицированных лиц благодаря расширению доступа к терапии, Четверг, 17 февраля 2022 г.

February 2022
Antibody-based treatment

CROI 2022: Antibody treatment for children Video

February 2022

CROI 2022: Hepatite C diminui nas pessoas com VIH à medida que o acesso ao tratamento aumenta, Quinta-feira, 17 de fevereiro de 2022

February 2022
The search for a cure

CROI 2022: HIV remission after transplant Video

February 2022

CROI 2022: Descenso de los casos de hepatitis C en personas con el VIH al aumentar el acceso al tratamiento, Jueves, 17 de febrero de 2022

February 2022

CROI 2022: L’hépatite C recule chez les personnes séropositives avec l’élargissement de l’accès au traitement, Jeudi 17 février 2022

February 2022
Pharmaceutical industry

Gilead comes back around on Hookipa HIV partnership, signing away $15M upfront and more down the line

Editor's pick
FierceBiotech
17 February 2022

CROI 2022: Hepatitis C declining in people with HIV as access to treatment broadens, Thursday 17 February 2022

February 2022
HIV testing policies & guidelines

More focused HIV testing in PEPFAR countries yields results

News
17 February 2022
Elimination of hepatitis C

New cases of hepatitis C declining in people with HIV as access to treatment broadens

News
17 February 2022
Vaccinations & immunisations

COVID-19 vaccine rates in people with HIV mirror those in the general population

News
17 February 2022
HIV treatment for children & young people

Point-of-care viral load tests did not improve viral suppression in Kenyan children

News
16 February 2022

КРОИ 2022: Жительница Нью-Йорка свободна от ВИЧ-инфекции после трансплантации стволовых клеток и через 14 месяцев после прекращения ВААРТ, Среда, 16 февраля 2022 г.

February 2022
Antibody-based treatment

One person remains undetectable without HIV drugs almost four years after using an antibody-based therapy

News
16 February 2022

CROI 2022: La ‘paziente di New York’, in remissione dall’HIV a 14 mesi dal trapianto di staminali, Mercoledì 16 febbraio 2022

February 2022

CROI 2022: Mulher em Nova Iorque sem VIH 14 meses após transplante de células estaminais, Quarta-feira, 16 de fevereiro de 2022

February 2022

CROI 2022: Una mujer de Nueva York, libre del VIH catorce meses después de un trasplante de células madre, Miércoles, 16 de febrero de 2022

February 2022

CROI 2022: Une New-Yorkaise est en rémission de VIH, 14 mois après une greffe de cellules souches, Mercredi 16 février 2022

February 2022
Bad science & bogus treatments

Fact Check - Australia halted the development of a COVID-19 vaccine in December 2020

Editor's pick
Reuters
16 February 2022
HIV testing policies & guidelines

Outpatient Clinics Efficient in Spotting Recent HIV in 3 African Countries

Editor's pick
NATAP
16 February 2022
Vaginal rings & topical PrEP

Study suggests young women prefer vaginal ring over oral PrEP for HIV prevention

Editor's pick
Healio
16 February 2022

CROI 2022: New York woman free of HIV 14 months after stem cell transplant, Wednesday 16 February 2022

February 2022